Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: results from the French National Health Data System.
OBJECTIVES To assess the risk of demyelinating events of TNF-inhibitors compared to conventional synthetic disease modifying anti-rheumatic drugs, in rheumatoid arthritis in real life setting. METHODS In this nationwide population-based cohort study conducted in the French National Health Data System, adult patients...